{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T08:14:46Z","timestamp":1773476086756,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"DOI":"10.1093\/cid\/ciq115","type":"journal-article","created":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T20:43:13Z","timestamp":1294605793000},"page":"s247-s252","source":"Crossref","is-referenced-by-count":61,"title":["The Lyme Disease Vaccine\u2014A Public Health Perspective"],"prefix":"10.1093","volume":"52","author":[{"given":"Angela K.","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,2,1]]},"reference":[{"key":"key\n\t\t\t\t20171014000232_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease","volume":"345","author":"Steere","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014000232_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI21681","article-title":"The emergence of Lyme disease","volume":"113","author":"Steere","year":"2004","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20171014000232_bib3","first-page":"1025","article-title":"Notice to readers: final 2009 reports of nationally notifiable infectious diseases","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014000232_bib4","first-page":"1","article-title":"Surveillance for Lyme disease\u2013United States, 1992-2006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"key\n\t\t\t\t20171014000232_bib5","first-page":"14","article-title":"Lyme disease\u2014Connecticut, 2008","volume":"29","author":"Ertel","year":"2009","journal-title":"Conn Epidemiologist"},{"key":"key\n\t\t\t\t20171014000232_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10651-006-0002-z","article-title":"Spatio-temporal patterns in county-level incidence and reporting of Lyme disease in the northeastern United States","volume":"14","author":"Waller","year":"2007","journal-title":"Environ Ecol Stat"},{"key":"key\n\t\t\t\t20171014000232_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014000232_bib8","first-page":"1","article-title":"Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20171014000232_bib9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(01)00500-X","article-title":"Adverse event reports following vaccination for Lyme disease: December 1998-July 2000","volume":"20","author":"Lathrop","year":"2002","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014000232_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(97)70056-8","article-title":"Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994","volume":"131","author":"Braun","year":"1997","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20171014000232_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20171014000232_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nm0402-311b","article-title":"Poor sales trigger vaccine withdrawal","volume":"8","author":"Hitt","year":"2002","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20171014000232_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1377\/hlthaff.24.3.631","article-title":"Why certain vaccines have been delayed or not developed at all","volume":"24","author":"Plotkin","year":"2005","journal-title":"Health Aff (Millwood)"},{"key":"key\n\t\t\t\t20171014000232_bib14","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMra021397","article-title":"How can we prevent Lyme disease?","volume":"348","author":"Hayes","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014000232_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4065\/76.7.713","article-title":"Prevention of Lyme disease: a review of the evidence","volume":"76","author":"Poland","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20171014000232_bib16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/vbz.2007.0221","article-title":"Knowledge, attitudes, and behaviors regarding Lyme disease prevention among Connecticut residents, 1999-2004","volume":"8","author":"Gould","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key\n\t\t\t\t20171014000232_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amepre.2009.04.026","article-title":"Peridomestic Lyme disease prevention: results of a population-based case-control study","volume":"37","author":"Connally","year":"2009","journal-title":"Am J Prev Med"},{"key":"key\n\t\t\t\t20171014000232_bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014000232_bib19","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0264-410X(00)00520-X","article-title":"The prevention of Lyme disease with vaccine","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014000232_bib20","first-page":"114","article-title":"Lyme disease\u2013The public dimension","volume":"2","author":"Dixon","year":"2007","journal-title":"Microbe"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/52\/suppl_3\/s247\/20909334\/ciq115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T00:02:41Z","timestamp":1507939361000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/52\/suppl_3\/s247\/444695\/The-Lyme-Disease-VaccineA-Public-Health"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":20,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2011,2,1]]},"published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciq115","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,2,1]]},"published":{"date-parts":[[2011,2,1]]}}}